Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A11QVV0
Tue, 15.06.2021
Heidelberg Pharma AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN.
Ad hoc announcement - Inside information pursuant to Article 17 MAR
Heidelberg Pharma AG to Raise Capital in a Private Placement
Ladenburg, Germany, 15 June 2021 - The Executive Management Board of Heidelberg Pharma (F [ … ]
Tue, 18.05.2021
Heidelberg Pharma AG
PRESS RELEASE
Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolutions
Ladenburg, Germany, 18 May 2021 - Heidelberg Pharma AG (FSE: HPHA) today announced that the shareholders of the Company approved the resolutions of the administration with large majorities (ranged from 98,40% to 99,99%) during the virtual Annual Gener [ … ]
Thu, 29.04.2021
Heidelberg Pharma AG
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021
- Application to initiate clinical trial of HDP-101 green-lighted by the FDA in February 2021
- Management team expanded
- New financing commitment for up to EUR 30 million obtained from main shareholder dievini
- New preclinical data from the ATAC technology plat [ … ]
Wed, 31.03.2021
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma to Present New Data on its Proprietary ATAC Technology Platform at the AACR Annual Meeting 2021
Ladenburg, Germany, 31 March 2021 - Heidelberg Pharma AG (FSE: HPHA) announced today that it will present preclinical data on its novel ATAC candidates HDP-102 and HDP-103 as well as data on synergistic effects of ATACs [ … ]
Mon, 21.12.2020
Heidelberg Pharma AG
Ad hoc announcement - Inside information pursuant to Article 17 MAR
Heidelberg Pharma AG Receives Shareholder Loan Based on an Existing Financing Commitment
Ladenburg, Germany, 21 December 2020 - Heidelberg Pharma AG (FSE: HPHA) today announced that it has signed a subordinated loan agreement for a total amount of EUR 15 million with its main sha [ … ]
Thu, 12.11.2020
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma will Present at German Equity Forum and Provides Update on Partner Activities for its Legacy Assets
- RedHill Biopharma plans Phase II/III trial with upamostat in COVID-19
- Telix Pharmaceuticals enters into strategic license and commercial partnership for China with radio-labelled antibody girentuximab
Ladenburg [ … ]
Thu, 05.11.2020
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020
- Heidelberg Pharma presents the design for the planned clinical study with HDP-101
- Partner MD Anderson Cancer Center presents in an oral presentation preclinical data with HDP-101 on the induction of an immune [ … ]
Thu, 08.10.2020
Heidelberg Pharma AG
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2020
- IND application to the FDA for the Phase I/IIa clinical trial of HDP-101 in preparation
- Private placement with gross proceeds of EUR 14.4 million and further financing commitment of EUR 15 million by majority shareholder dievini received
- Expansion of own AT [ … ]
Tue, 29.09.2020
Heidelberg Pharma AG
Ad hoc announcement - Inside information pursuant to Article 17 MAR
Heidelberg Pharma AG Announces Adjustment of Guidance
Ladenburg, Germany, 29 September 2020 - Heidelberg Pharma AG (FSE: HPHA) today announced that it has adjusted its guidance for the current fiscal year published in March 2020. This is due to increased operating expenses for th [ … ]
Mon, 14.09.2020
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Receives Milestone Payment from Partner Magenta
Ladenburg, Germany, 14 September 2020 - Heidelberg Pharma AG (FSE: HPHA) announced today that it has received a milestone payment from its cooperation partner Magenta Therapeutics, Cambridge, MA, USA, (Magenta) (NASDAQ: MGTA) associated with the initiation of the GLP [ … ]